StageAccelerator/Incubator Backed
Employees8
LocationCupertino, CA
About
PATHOMIQ develops an AI platform that integrates morphology and genomics from tissue images to predict cancer treatment response and identify molecular biomarkers. The platform analyzes H&E-stained slides to predict outcomes, genotypes, and therapy response for prostate and breast cancers, serving pathology labs, hospitals, cancer centers, and biopharma companies. The company is based in Cupertino, California.
Product
- Value proposition
- AI-powered interpretable multiomics platform for precision pathology and predictive testing to personalize cancer treatment and guide biomarker discovery
- Target customers
- pathology labs, hospitals, cancer centers, biopharma (oncology)
Founders
- Parag Jain — Co-Founder and Strategic Advisor
- Wei Huang — Co-Founder and Head of Pathology
- Hirak Basu — Co-Founder and Molecular Scientist
- Shivaani Kummar — Co-Founder
- Rajat Roy — CEO and Co-Founder
Categories
AI in pathologyprecision medicinebiomarker discoverymultomics
Products
pathomiq AI platformpredictive testsphenotype atlasmolecular biomarker discovery tools
Key features
interpretable AI predictionsmultiomics integration (morphology + genomics)cellular/glandular quantificationsgenomic expression mappingphenotype atlas trained from diverse tissue slideshigh-confidence predictions with biologically interpretable evidence
Technologies
AI/MLdeep learningcomputer visionhistopathology (H&E) analysisspatial proteogenomicsmultiomics integration
Integrations
EHRs / pathology systems
Target conditions
prostate cancerbreast cancerbladder cancertriple-negative breast cancerER+/HER2- breast cancer
Care settings
clinichospitallaboratoryvirtual
Investors
IIT Startups
News
- Our Team – PATHOMIQ · 2026-03-14T00:00:00.000Z
- Myriad Genetics Partners with PATHOMIQ to add Artificial · 2025-02-24T08:30:00.000Z
- Independent Study Validates PathomIQ AI Digital Pathology Platform for Prostate Cancer Prognosis | 360Dx · 2025-07-07T14:19:36.000Z
- Haynes Boone Guides PATHOMIQ in AI Diagnostics Deal with Myriad Genetics to Transform Cancer Care | News | Haynes Boone · 2025-02-27T23:35:52.000Z
- Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio - BioSpace · 2025-02-25T07:30:36.000Z
- Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer ... · 2026-05-26T00:00:00.000Z
Browse similar startups
Related startups
- PEDIATRIC HEALTH AND WELLNESS — Rocklin, CA
- Pediatrics Technologies — San Francisco, CA
- Phinomics — San Carlos, CA
- Physera — San Francisco, CA
- PhyxUp Health — San Francisco, CA
- PointHealth AI — San Francisco, CA
- PATIENT CARE COORDINATION, INC. — Philadelphia, PA
- Payson Healthcare Management, Inc. — Payson, AZ
- Pebble — Seattle, WA
- PEDIATRIC ASSOCIATES OF PAOLI — Paoli, PA
- PEDIATRIC ASSOCIATES OF TOPEKA, LLC — Topeka, KS
- PEDIATRIC CARE CENTER
Profile updated Jul 29, 2026. Sources: pathomiq.com
